Search results
A billionaire hopes to upgrade the Hubble Telescope on a private SpaceX mission, but could it really...
Space via Yahoo News· 1 day agoJared Isaacman, the billionaire funder and commander of the Polaris Program missions, spoke on...
Unlocking the Door to Men's Health: A Focus on Urological Wellness
Providence Business News· 3 days agoMen often find themselves navigating a maze of misconceptions and reluctance when it comes to...
Things are finally looking up for the Voyager 1 interstellar spacecraft
Space via Yahoo News· 3 days agoIt is easy to see why Voyager 1 is among the most beloved robotic space explorers we have — and it...
How Medicare benefits would change under plan proposed by doctors
Newsweek· 4 days agoDoctors are pushing for a key Medicare change that would expand coverage to your next dentist...
Down 72%. Is Ginkgo Bioworks a Buy on the Dip?
The Motley Fool via AOL· 1 day agoReasons to buy Ginkgo Bioworks The company's cell engineering platform combines robotics and artificial intelligence (AI) to produce new cell lines for its clients. This is ...
Regional employers gather in Litchfield to strengthen talent pipeline
The Daily Telegram via Yahoo Finance· 2 days agoIn the Lenawee, Jackson and Hillsdale areas, collaboratives are dedicated to health care, robotics,...
A billionaire hopes to upgrade the Hubble Telescope on a private SpaceX mission, but could it really...
SPACE.com· 1 day agoNASA's iconic Hubble observatory still has years of life left in it, and there are ideas in the...
Qiming Venture Partners Promotes Alex Zhou to Managing Partner
WKBN 27 Youngstown· 4 days agoQiming Venture Partners, a global-leading venture capital firm, is pleased to announce the promotion of Alex Zhou to Managing Partner. As a Qiming home-grown Managing Partner, Alex first joined ...
Stereotaxis' (STXS) RMN System to Aid in Treating Arrhythmias
Zacks· 2 days agoStereotaxis (STXS) announces the completion of treatment of first heart rhythm patients with its...
Down 72%. Is Ginkgo Bioworks a Buy on the Dip? | The Motley Fool
The Motley Fool· 1 day agoIt has been difficult to be a shareholder of Ginkgo Bioworks (DNA 0.70%) over the past year. The...
